Titan Pharmaceuticals Inc. (NASDAQ: TTNP)
$3.3800
N/A ( +0.30% ) 2.3K
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Market Data
Open
$3.3800
Previous close
$3.3800
Volume
2.3K
Market cap
$3.02M
Day range
$3.1710 - $3.4500
52 week range
$3.0300 - $14.8000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 48 | Jan 03, 2025 |
8-k | 8K-related | 13 | Dec 06, 2024 |
8-k | 8K-related | 19 | Nov 27, 2024 |
nt | Quarterly Reports | 1 | Nov 15, 2024 |
8-k | 8K-related | 13 | Nov 08, 2024 |
8-k | 8K-related | 13 | Oct 24, 2024 |
8-k | 8K-related | 16 | Aug 19, 2024 |
10-q | Quarterly Reports | 44 | Aug 15, 2024 |
nt | Quarterly Reports | 1 | Aug 15, 2024 |
10-q | Quarterly Reports | 46 | May 15, 2024 |